Kidney International Supplements最新文献

{"title":"Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey","authors":"Valerie A. Luyckx ,&nbsp;Brendan Smyth ,&nbsp;David C.H. Harris ,&nbsp;Roberto Pecoits-Filho","doi":"10.1016/j.kisu.2019.11.005","DOIUrl":"10.1016/j.kisu.2019.11.005","url":null,"abstract":"<div><p>Dialysis provisions and end-stage kidney disease (ESKD) care represents an important challenge, particularly in low-resource settings. The purpose of this project was to survey nephrologists from low- and lower middle-income countries about their experiences in the following domains: (i) <em>Dialysis funding and eligibility</em>; (ii) <em>dialysis-procurement mechanisms</em>; (iii) <em>clinical protocols for dialysis</em>; (iv) <em>monitoring of dialysis outcomes</em>; and (v) <em>barriers to care for ESKD.</em><span> One hundred and twenty responses from 31 low- and middle-income countries, from 8 ISN regions, were included in the analysis. When stratified by World Bank country income status, responses were received from 7 low-income countries, 12 lower middle-income countries, and 12 upper middle-income countries. Eighty-eight documents from 18 countries were uploaded, including country or institutional guidelines, protocols, and standard operating procedures. The International Society of Nephrology aims to develop a set of guidance documents that put forward a considered approach to dialysis provisions and ESKD care within resource limitations. As an initial step in this project, local practitioners from low-resource settings were surveyed about their experiences with dialysis funding, eligibility, procurement and their use of guidance documents, and how practices and procedures may have been developed with adaptations to the local circumstances. In this manuscript we describe the methodology and the main findings from the survey using an integrated quantitative and qualitative approach.</span></p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Pages e10-e18"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Considerations on equity in management of end-stage kidney disease in low- and middle-income countries","authors":"Wim Van Biesen ,&nbsp;Vivekanand Jha ,&nbsp;Ali K. Abu-Alfa ,&nbsp;Sharon P. Andreoli ,&nbsp;Gloria Ashuntantang ,&nbsp;Bassam Bernieh ,&nbsp;Edwina Brown ,&nbsp;Yuqing Chen ,&nbsp;Rosanna Coppo ,&nbsp;Cecile Couchoud ,&nbsp;Brett Cullis ,&nbsp;Walter Douthat ,&nbsp;Felicia U. Eke ,&nbsp;Brenda Hemmelgarn ,&nbsp;Fan Fan Hou ,&nbsp;Nathan W. Levin ,&nbsp;Valerie A. Luyckx ,&nbsp;Rachael L. Morton ,&nbsp;Mohammed Rafique Moosa ,&nbsp;Fliss E.M. Murtagh ,&nbsp;Guillermo Garcia Garcia","doi":"10.1016/j.kisu.2019.11.004","DOIUrl":"10.1016/j.kisu.2019.11.004","url":null,"abstract":"<div><p><span>Achievement of equity in health requires development of a health system<span> in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy<span> (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care<span> spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or </span></span></span></span>peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Pages e63-e71"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Title Page","authors":"","doi":"10.1016/S2157-1716(20)30003-4","DOIUrl":"https://doi.org/10.1016/S2157-1716(20)30003-4","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Page A3"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2157-1716(20)30003-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72060675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing the ethical framework of end-stage kidney disease care: from practice to policy","authors":"Valerie A. Luyckx ,&nbsp;Dominique E. Martin ,&nbsp;Mohammed Rafique Moosa ,&nbsp;Aminu K. Bello ,&nbsp;Ezequiel Bellorin-Font ,&nbsp;Tak Mao Chan ,&nbsp;Rolando Claure-Del Granado ,&nbsp;Walter Douthat ,&nbsp;Somchai Eiam-Ong ,&nbsp;Felicia U. Eke ,&nbsp;Bak Leong Goh ,&nbsp;Vivekanand Jha ,&nbsp;Evie Kendal ,&nbsp;Adrian Liew ,&nbsp;Yewondwossen Tadesse Mengistu ,&nbsp;Elmi Muller ,&nbsp;Ikechi G. Okpechi ,&nbsp;Eric Rondeau ,&nbsp;Manisha Sahay ,&nbsp;Michele Trask ,&nbsp;Tushar Vachharajani","doi":"10.1016/j.kisu.2019.11.003","DOIUrl":"10.1016/j.kisu.2019.11.003","url":null,"abstract":"<div><p><span>Ethical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to </span>kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care. End-of-life decision-making in the context of ESKD care in all countries may also create ethical dilemmas for policy makers, professionals, patients, and their families. This review outlines several ethical implications of the complex challenges that arise in the management of ESKD care around the world. We argue that more work is required to develop the ethics of ESKD care, so as to provide ethical guidance in decision-making and education and training for professionals that will support ethical practice in delivery of ESKD care. We briefly review steps that may be required to accomplish this goal, discussing potential barriers and strategies for success.</p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Pages e72-e77"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The second Global Kidney Health Summit outputs: developing a strategic plan to increase access to integrated end-stage kidney disease care worldwide","authors":"David C.H. Harris ,&nbsp;Simon J. Davies ,&nbsp;Fredric O. Finkelstein ,&nbsp;Vivekanand Jha","doi":"10.1016/j.kisu.2019.09.001","DOIUrl":"10.1016/j.kisu.2019.09.001","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Pages e1-e2"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37723115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Framework for establishing integrated kidney care programs in low- and middle-income countries","authors":"Marcello Tonelli ,&nbsp;Victoria Nkunu ,&nbsp;Cherian Varghese ,&nbsp;Ali K. Abu-Alfa ,&nbsp;Mona N. Alrukhaimi ,&nbsp;Bassam Bernieh ,&nbsp;Louise Fox ,&nbsp;John Gill ,&nbsp;David C.H. Harris ,&nbsp;Fan Fan Hou ,&nbsp;Philip J. O’Connell ,&nbsp;Harun Ur Rashid ,&nbsp;Abdou Niang ,&nbsp;Shahrzad Ossareh ,&nbsp;Vladimir Tesar ,&nbsp;Elena Zakharova ,&nbsp;Chih-Wei Yang","doi":"10.1016/j.kisu.2019.11.002","DOIUrl":"10.1016/j.kisu.2019.11.002","url":null,"abstract":"<div><p><span>Secular increases in the burden of kidney failure is a major challenge for health systems<span> worldwide, especially in low- and middle-income countries (LMICs) due to growing demand for expensive kidney replacement therapies<span><span><span>. In LMICs with limited resources, the priority of providing kidney replacement therapies must be weighed against the prevention and treatment of </span>chronic kidney disease<span>, other kidney disorders such as </span></span>acute kidney injury<span>, and other noncommunicable diseases, as well as other urgent </span></span></span></span>public health<span><span> needs. Kidney failure is potentially preventable—not just through primary prevention of risk factors for kidney disease such as hypertension and diabetes, but also by timely management of established chronic kidney disease. Among people with established or incipient kidney failure, there are 3 key treatment strategies—conservative care, kidney transplantation, and dialysis—each of which has its own benefits. Joining up </span>preventive care for people with or at risk for milder forms of chronic kidney disease with all 3 therapies for kidney failure (and developing synergistic links between the different treatment options) is termed “integrated kidney care” and has potential benefits for patients, families, and providers. In addition, because integrated kidney care implicitly considers resource use, it should facilitate a more sustainable approach to managing kidney failure than providing one or more of its components separately. There is currently no agreed framework that LMIC governments can use to establish and/or scale up programs to prevent and treat kidney failure or join up these programs to provide integrated kidney care. This review presents a suggested framework for establishing integrated kidney care programs, focusing on the anticipated needs of policy makers in LMICs.</span></p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Pages e19-e23"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce","authors":"Charles R. Swanepoel ,&nbsp;Mignon I. McCulloch ,&nbsp;Georgi Abraham ,&nbsp;Jo-Ann Donner ,&nbsp;Mona N. Alrukhaimi ,&nbsp;Peter G. Blake ,&nbsp;Sakarn Bunnag ,&nbsp;Stefaan Claus ,&nbsp;Gavin Dreyer ,&nbsp;Mohammad A. Ghnaimat ,&nbsp;Fuad M. Ibhais ,&nbsp;Adrian Liew ,&nbsp;Marla McKnight ,&nbsp;Yewondwossen Tadesse Mengistu ,&nbsp;Saraladevi Naicker ,&nbsp;Abdou Niang ,&nbsp;Gregorio T. Obrador ,&nbsp;Jeffrey Perl ,&nbsp;Harun Ur Rashid ,&nbsp;Marcello Tonelli ,&nbsp;Fredric O. Finkelstein","doi":"10.1016/j.kisu.2019.11.007","DOIUrl":"10.1016/j.kisu.2019.11.007","url":null,"abstract":"<div><p><span><span>Prevention and early detection of kidney diseases in adults and children should be a priority for any government health department. This is particularly pertinent in the low-middle-income countries, mostly in Asia, Africa, Latin America, and the Caribbean, where up to 7 million people die because of lack of end-stage kidney disease </span>treatment. The </span>nephrology<span> workforce (nurses, technicians, and doctors) is limited in these countries and expanding the size and expertise of the workforce is essential to permit expansion of treatment for both chronic kidney disease and end-stage kidney disease. To achieve this will require sustained action and commitment from governments, academic medical centers, local nephrology societies, and the international nephrology community.</span></p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Pages e49-e54"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to “Zhang L, Zhao M-H, Zuo L, et al., on behalf of CK-NET Group. China Kidney Disease Network (CK-NET) 2015 Annual Data Report.” Kidney Int Suppl. 2019;9:e1–e81","authors":"","doi":"10.1016/j.kisu.2019.05.001","DOIUrl":"https://doi.org/10.1016/j.kisu.2019.05.001","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Page e95"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72060609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Global case studies for chronic kidney disease/end-stage kidney disease care","authors":"Chih-Wei Yang ,&nbsp;David C.H. Harris ,&nbsp;Valerie A. Luyckx ,&nbsp;Masaomi Nangaku ,&nbsp;Fan Fan Hou ,&nbsp;Guillermo Garcia Garcia ,&nbsp;Hasan Abu-Aisha ,&nbsp;Abdou Niang ,&nbsp;Laura Sola ,&nbsp;Sakarn Bunnag ,&nbsp;Somchai Eiam-Ong ,&nbsp;Kriang Tungsanga ,&nbsp;Marie Richards ,&nbsp;Nick Richards ,&nbsp;Bak Leong Goh ,&nbsp;Gavin Dreyer ,&nbsp;Rhys Evans ,&nbsp;Henry Mzingajira ,&nbsp;Ahmed Twahir ,&nbsp;Mignon I. McCulloch ,&nbsp;Marcello Tonelli","doi":"10.1016/j.kisu.2019.11.010","DOIUrl":"10.1016/j.kisu.2019.11.010","url":null,"abstract":"<div><p><span>The prevalence of chronic kidney disease and its risk factors is increasing worldwide, and the rapid rise in global need for end-stage kidney disease care is a major challenge for </span>health systems<span>, particularly in low- and middle-income countries. Countries are responding to the challenge of end-stage kidney disease in different ways, with variable provision of the components of a kidney care strategy, including effective prevention, detection, conservative care, kidney transplantation, and an appropriate mix of dialysis modalities. This collection of case studies is from 15 countries from around the world and offers valuable learning examples from a variety of contexts. The variability in approaches may be explained by country differences in burden of disease, available human or financial resources, income status, and cost structures. In addition, cultural considerations, political context, and competing interests from other stakeholders must be considered. Although the approaches taken have often varied substantially, a common theme is the potential benefits of multistakeholder engagement aimed at improving the availability and scope of integrated kidney care.</span></p></div>","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"10 1","pages":"Pages e24-e48"},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.kisu.2019.11.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Subscription Information","authors":"","doi":"10.1016/s2157-1716(20)30002-2","DOIUrl":"https://doi.org/10.1016/s2157-1716(20)30002-2","url":null,"abstract":"","PeriodicalId":48895,"journal":{"name":"Kidney International Supplements","volume":"16 1","pages":""},"PeriodicalIF":5.5,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89925349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}